Press release
U.S. Lung Cancer Surgery Market Grows as Robotic & Minimally Invasive Techniques Transform Care
Leander, Texas, United States - Dec.17.2025As per DataM Intelligence research report "Global Lung Cancer Surgery Market is growing with a high 3.6 % CAGR from 2024 to 2031."Growing prevalence of lung cancer, rising air pollution, increasing smoking rates, and advancements in minimally invasive and robotic-assisted surgical techniques are driving the lung cancer surgery market.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/lung-cancer-surgery-market?sindhuri
Lung Cancer Surgery Market: Recent Industry Developments
United States: Recent Industry Developments
✅ In November 2025, Intuitive Surgical expanded its da Vinci robotic systems with enhanced features for thoracoscopic lung resections, improving precision and outcomes in minimally invasive lung cancer surgeries across U.S. hospitals.
✅ In October 2025, Ethicon (Johnson & Johnson) launched advanced energy devices optimized for lung cancer procedures, reducing operative time and complications in thoracotomy and VATS surgeries.
✅ In September 2025, Accuray Incorporated introduced upgrades to its CyberKnife system for precise stereotactic body radiation therapy as an adjunct to surgery in early-stage non-small cell lung cancer.
✅ In August 2025, Olympus Corporation advanced its endoscopic visualization platforms for better intraoperative guidance in segmentectomy and lobectomy procedures.
Japan: Recent Industry Developments
✅ In November 2025, Olympus Corporation (Japan) collaborated on next-generation VATS tools tailored for lung cancer resection, supporting Japan's high-volume thoracic surgery programs.
✅ In October 2025, Japanese medical institutions expanded adoption of robotic-assisted lung surgeries using systems from international partners, focusing on elderly patients.
✅ In September 2025, Regional advancements in minimally invasive techniques were deployed in pilot projects for NSCLC treatment in urban centers.
✅ In August 2025, Partnerships initiated for AI-integrated surgical planning in lung cancer operations, enhancing precision in Japanese healthcare facilities.
Lung Cancer Surgery Market: Drivers
The lung cancer surgery market is driven by the escalating global prevalence of lung cancer, fueled by smoking, air pollution, and an aging population. Technological advancements in minimally invasive procedures, such as video-assisted thoracoscopic surgery (VATS), robotic-assisted surgery, and segmentectomy, offer reduced recovery times, less pain, and better outcomes compared to traditional thoracotomy. Increasing awareness, early screening programs, and R&D investments are promoting adoption of advanced surgical equipment and techniques.
Collaboration among device manufacturers, hospitals, and research bodies is accelerating innovations in monitoring, visualizing systems, and powered instruments. Rising demand for lung-sparing surgeries like segmentectomy for early-stage NSCLC, along with supportive healthcare policies in developed regions, further boosts growth. With continuous improvements in surgical precision, patient outcomes, and accessibility in emerging markets, the lung cancer surgery market is poised for robust expansion.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lung-cancer-surgery-market?sindhuri
Lung Cancer Surgery Market: Major Players
Ethicon US LLC, Intuitive Surgical Inc, Olympus Corporation, Accuray Inc, AngioDynamics Inc, Teleflex Inc., Shanghai Ezisurg Medical (PRC), Shanghai Bojin Medical Instrument Co., Ltd. (PRC), Taizhou Rich Medical Products Co., Ltd. (PRC), Zhejiang Honsun Medical Technology Co., Ltd. (PRC).
Segment Covered in the Lung Cancer Surgery Market:
By Surgical Procedure
Segmentectomy dominates the market, driven by its preference for early-stage NSCLC with better preservation of lung function and survival rates. Minimally Invasive Surgeries (including VATS) are growing rapidly, followed by Lobectomy, Sleeve Resection, and Pneumonectomy.
By Surgical Devices
Surgical Instruments lead with the largest share and fastest growth, supported by rising procedures and demand for advanced hand and powered tools. Monitoring and Visualizing Systems follow.
By End-User
Hospitals hold the largest share due to comprehensive infrastructure and high procedure volumes. Ambulatory Surgical Centers and Clinics are emerging.
Regional Analysis
North America - Largest Share
North America dominates with high lung cancer incidence, advanced healthcare, key player presence, and rapid adoption of robotic and minimally invasive techniques in the U.S.
Asia-Pacific - Fastest Growing
Asia-Pacific expands rapidly due to rising pollution, smoking rates, aging population, and improving surgical access in China, India, and Japan.
Europe - Significant Share
Europe grows steadily with focus on early detection and advanced therapies.
South America - Emerging Share
South America advances with increasing awareness and infrastructure.
Middle East & Africa - Growing Share
Middle East & Africa progress through healthcare investments.
Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=lung-cancer-surgery-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Lung Cancer Surgery Market Grows as Robotic & Minimally Invasive Techniques Transform Care here
News-ID: 4318382 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
United States Facility Management Robotics Market Strengthens Every Ounce at 7.6 …
Leander, Texas and TOKYO, Japan - Dec. 17, 2025. According to DataM Intelligence, the United States Facility Management Robotics Market Size reached USD 3,659 million in 2024 and is projected to reach USD 6,553 million by 2032, registering a robust CAGR of 7.67% during 2025-2032. The surging demand for automated cleaning and security solutions, persistent labor shortages across commercial sectors, and advancements in AI-driven navigation and sensor technologies are fueling…
United States Appendix Cancer Drugs Market Advances as Targeted Therapies, Drug …
Leander, Texas, United States - Dec.17.2025
As per DataM Intelligence research report Rising prevalence of appendix cancer, advancements in targeted therapies, and increasing R&D initiatives are driving the development of innovative drugs for appendix cancer treatment.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/appendix-cancer-drugs-market?sindhuri
Appendix Cancer Drugs Market: Recent Industry Developments
United States: Recent Industry Developments
✅ In November 2025, Pfizer Inc. advanced its oncology pipeline with expanded research into targeted…
United States Hospitality Service Robots Market Strengthens Every Ounce at 12.7% …
Leander, Texas and TOKYO, Japan - Dec. 17, 2025. According to DataM Intelligence, the United States Hospitality Service Robots Market Size reached USD 1,260 million in 2024 and is expected to reach USD 3,252 million by 2032, registering a robust CAGR of 12.7% during 2025-2032. The surging demand for automated guest service solutions, the persistent labor shortages in hotels and restaurants, and advancements in AI-powered navigation and collaborative robot technologies…
United States Hormone Refractory Prostate Cancer Market Expands at 6.2% CAGR as …
Leander, Texas, United States - Dec.17.2025
As per DataM Intelligence research report "Global Hormone Refractory Prostate Cancer Market is growing with a high 6.2% CAGR during the forecast period 2024-2031.". Increasing prevalence of prostate cancer, strong pipeline of innovative therapies, and advancements in targeted treatments are driving the development of effective solutions for hormone refractory (castration-resistant) prostate cancer.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/hormone-refractory-prostate-cancer-market?sindhuri
Hormone Refractory Prostate…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…
